Intima Bioscience has conducted a clinical trial at the University of Minnesota Masonic Cancer Center.
Please watch the video below to learn more about our proprietary CISH checkpoint.
Intima Bioscience has conducted a clinical trial at the University of Minnesota Masonic Cancer Center.
Please watch the video below to learn more about our proprietary CISH checkpoint.
A clinical trial employing CRISPR genetically engineered CISH-knockout T-cells as a model system to evaluate the safety and efficacy of this classically undruggable intracellular target.
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering